Bases structurales de la régulation des cytokines par les héparanes sulfates: régulation génique et optimisation d'un inhibiteur de l'interféron-gamma, p.296 ,
, Les bases de l'immunologie fondamentale et clinique -9782294752421 |
, ebooks, revues et traités EMC pour toutes spécialités médicales et paramédicales
,
IL-12 et IFN-? : un axe clé de l'immunité antimycobactérienne chez l'homme. médecine/sciences, vol.17, pp.1112-1121, 2001. ,
Le système interféron : structure, biologie, applications. Ann Rech Vét, vol.20, p.38, 1989. ,
,
, /S0969212601005676?token=26D837A768CE277BAF61E8A2E48E 916E3F4D94475F6D0F1134B463E7A2B3A4F46373637E051D107D2717
Dynamiques moléculaire et membranaire du récepteur de l'interféron gamma : pour un sucre de trop ! médecine/sciences, vol.33, pp.707-717, 2017. ,
Laboratory evaluation of the IFN-? circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease, Crit Rev Clin Lab Sci. mai, vol.55, issue.3, pp.184-204, 2018. ,
Cross-regulation of Signaling and Immune Responses by IFN-? and STAT1. Immunity, vol.31, p.50, 2009. ,
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor, EMBO J. avr, vol.10, issue.4, pp.927-959, 1991. ,
Inborn Errors of Human JAKs and STATs, Immunity. 20 avr, vol.36, issue.4, p.28, 2012. ,
The Roles of Type I Interferon in Bacterial Infection, Cell Host Microbe. juin, vol.19, issue.6, pp.760-769, 2016. ,
A two-signal model for regulation of immunoglobulin isotype switching, FASEB J. nov, vol.6, issue.14, p.52, 1992. ,
Regulation of Interferon-? During Innate and Adaptive Immune Responses, Advances in Immunology ,
CYTOKINES IN THE BALANCE OF PROTECTION AND PATHOLOGY DURING MYCOBACTERIAL INFECTIONS, Adv Exp Med Biol, vol.783, pp.121-161, 2013. ,
Antigen presentation by MHC class I and its regulation by interferon ?, Curr Opin Immunol. févr, vol.11, issue.1, p.81, 1999. ,
, Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity, J Exp Med. 1 sept, vol.158, issue.3, p.89, 1983.
The COOHterminal nuclear localization sequence of interferon ? regulates STAT1? nuclear translocation at an intracellular site, p.11 ,
Interferon-?: an overview of signals, mechanisms and functions, J Leukoc Biol, vol.75, issue.2, p.89, 2004. ,
Maîtrise en médecine expérimentale de l ,
,
Pattern recognition receptors and coordinated cellular pathways involved in tuberculosis immunopathogenesis: Emerging concepts and perspectives, Mol Immunol. juill, vol.87, pp.240-248, 2017. ,
Interferon-? Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection, Emerg Infect Dis. juin, vol.22, issue.6, pp.1124-1130, 2016. ,
Mycobactéries non tuberculeuses : quoi de neuf ? ,
Infections mycobactériennes non tuberculeuses -Maladies infectieuses, Édition professionnelle du Manuel MSD ,
,
,
, Thalidomide Stimulates T Cell Responses and Interleukin, vol.12
, Production in HIV-Infected Patients
,
, Rituximab Restores IFN-?-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-?
, J Clin Immunol, vol.37, issue.7, p.9, 2017.
Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection ,
, J Immunol Res, vol.30, 2018.
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood, Immunol Rev. mars, vol.264, issue.1, p.20, 2015. ,
Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies, J Exp Med, vol.211, issue.11, pp.2137-2186, 2014. ,
Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases, Int J Infect Dis IJID Off Publ Int Soc Infect Dis. mai, vol.15, issue.5, pp.305-318, 2011. ,
Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-? immunity, Semin Immunol. déc, vol.26, issue.6, pp.454-70, 2014. ,
Inherited disorders of the IL-12-IFN-? axis in patients with disseminated BCG infection, Eur J Pediatr. déc, vol.164, issue.12, pp.753-760, 2005. ,
Partial recessive IFN-?R1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds, Hum Mol Genet. 15 avr, vol.20, issue.8, pp.1509-1532, 2011. ,
, Inherited disorders of cytokines | Ovid
,
Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection, J Clin Invest. 1 juin, vol.101, issue.11, pp.2364-2373, 1998. ,
, Syndrome de susceptibilite mendélienne aux infections mycobacteriennes : défauts de l'axe Interleukine-12 -Interféron-? -EM|consulte
Inborn errors of IL-12/23-and IFN-?-mediated immunity: molecular, cellular, and clinical features, Semin Immunol. déc, vol.18, issue.6, p.61, 2006. ,
Recherche des facteurs génétiques contrôlant la réponse à l'infection par Mycobacterium tuberculosis et le développement d'une tuberculose maladie, p.213, 2017. ,
Déficits immunitaires de l'adulte, p.70 ,
Adult-onset immunodeficiency in Thailand and Taiwan, N Engl J Med. 23 août, vol.367, issue.8, p.725, 2012. ,
Naturally occurring anti-IFN-? autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans, Blood. 15 janv, vol.103, issue.2, p.5, 2004. ,
Infections récurrentes à mycobactéries atypiques chez l'adulte : attention aux autoanticorps anti-interféron-gamma ! Rev Médecine Interne, vol.33, pp.103-109, 2012. ,
Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies, J Clin Immunol. mai, vol.35, issue.4, pp.361-366, 2015. ,
Reactive and Infective Dermatoses Associated with Adult-Onset Immunodeficiency due to Anti-Interferon-Gamma Autoantibody: Sweet's Syndrome and Beyond, Dermatology, vol.226, issue.2, pp.157-66, 2013. ,
Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients, J Infect Chemother. janv, vol.20, issue.1, pp.52-58, 2014. ,
The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-? Autoantibodies, J Clin Immunol, vol.34, issue.8, pp.928-960, 2014. ,
Disseminated non-tuberculous mycobacterial infection caused by antiinterferon-? autoantibodies in a patient of very advanced age, Geriatr Gerontol Int, vol.18, issue.7, pp.1132-1135, 2018. ,
Disseminated Nontuberculous Mycobacterial Infection Associated With Acquired Immunodeficiency Due to Anti-Interferon ? Autoantibodies ,
, Open Forum Infect Dis, vol.16
,
First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies, New Microbes New Infect, vol.27, pp.4-6, 2018. ,
Clinical Significance of Interferon-? Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease, Clin Infect Dis. 3 avr, vol.66, issue.8, pp.1239-1284, 2018. ,
Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis 85 possibly secondary to anti-interferon-? autoantibody formation, BMC, vol.19 ,
Anti-IFN-? Autoantibodies in Disseminated Nontuberculous Mycobacterial Infections, J Immunol, vol.175, issue.7, pp.4769-76, 2005. ,
Autoantibody to Interferon-gamma Associated with Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand. Rottenberg ME, éditeur, PLoS ONE. 27 sept, vol.8, issue.9, p.76371, 2013. ,
Anti-interferon-? autoantibody and opportunistic infections: case series and review of the literature, Infection. févr, vol.39, issue.1, pp.65-71, 2011. ,
Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review ,
, Diagn Microbiol Infect Dis. 1 août, vol.88, issue.4, p.15, 2017.
Functional Analysis of Anti-cytokine Autoantibodies Using Flow Cytometry. Front Immunol, vol.12 ,
Recurrence of Disseminated Mycobacterium avium Complex Disease in a Patient with Anti-Gamma Interferon Autoantibodies by Reinfection, J Clin Microbiol. avr, vol.53, issue.4, pp.1436-1444, 2015. ,
Identification of a major epitope by anti-interferon-? autoantibodies in patients with mycobacterial disease, Nat Med. sept, vol.22, issue.9, pp.994-1001, 2016. ,
, , p.86
, interferon-? antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms, Exp Biol Med. avr, vol.243, issue.7, pp.621-627, 2018.
Genetic dissection of immunity to mycobacteria: the human model, Annu Rev Immunol, vol.20, pp.581-620, 2002. ,
Anti-IFN-? autoantibodies are strongly associated with, J Allergy Clin Immunol. mars, vol.137, issue.3, pp.945-948, 2016. ,
Interferon gamma in autoimmunity: A complicated player on a complex stage, Cytokine. juill, vol.74, issue.1, p.26, 2015. ,
Defining criteria for autoimmune diseases (Witebsky's postulates revisited), Immunol Today. sept, vol.14, issue.9, p.30, 1993. ,
Blockade Effects of Anti-Interferon-(IFN-) ? Autoantibodies on IFN-?-Regulated Antimicrobial Immunity, J Immunol Res, 2019. ,
Immunodeficiency secondary to anti-cytokine autoantibodies, Curr Opin Allergy Clin Immunol. déc, vol.10, issue.6, p.41, 2010. ,
, Site de vulgarisation scientifique
, , 2013.
Le quantiFERON : qu'est ce que c'est ? à quoi ca sert ? :3. 68. 38-1-e10.pdf ,
Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti ,
Anti-interferon-? autoantibody in a patient with disseminated Mycobacterium avium complex, J Infect Chemother. 1 janv, vol.15, issue.2, p.22, 2009. ,
Patients with inhibitory and neutralizing auto-antibodies to interferon-? resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to ,
, Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases, Immunobiology. mai, vol.218, issue.5, pp.762-71, 2013.
Heparin inhibits interferon-? signaling in human endometrial stromal cells by interference with the cellular binding of interferon-?, Fertil Steril. mars, vol.95, issue.4, pp.1272-1279, 2011. ,
Determination of Human Anticytokine Autoantibody Profiles Using a Particle-Based Approach, J Clin Immunol. avr, vol.32, issue.2, p.45, 2012. ,
, Cytokine assays: An assessment of the preparation and treatment of blood and tissue samples, Methods. 15 mai, vol.61, issue.1, pp.10-17, 2013.
Repurposing QuantiFERON for Detection of Neutralizing Interferon-? Autoantibodies in Patients With Nontuberculous Mycobacterial Infections, Clin Infect Dis. 1 août, vol.65, issue.3, pp.518-539, 2017. ,
Clinical Reevaluation of the QuantiFERON TB-2G Test as a Diagnostic Method for Differentiating Active Tuberculosis from Nontuberculous Mycobacteriosis, Clin Infect Dis. 15 déc, vol.43, issue.12, pp.1540-1546, 2006. ,
, Culture Filtrate Protein 10 CMH : Complexe Majeur d'Histocompatibilité CMV : CytoMégaloVirus CPA : Cellules Présentatrices d'Antigènes CV : Coefficient de Variation CYBB : Cytochrome B-245 Beta Chain DO : Densité Optique EFS : Établissement Français du Sang ELISA: Enzyme-Linked immunoSorbent Assay ESAT-6: Early Secreted Antigenic Target 6 kDa protein ET : Écart-Type HAS : Haute Autorité de Santé HLA: Human Leukocytes Antigene HRP: HoreRadish Peroxidase IgG : Immunoglobulines G IFN gamma: Interféron gamma IKK: Inhibitor of NFkB Kinase IL-12: Interleukine 12 IRF: Interferon Regulatory Factor JAK : Janus Kinase MAI : Maladies Auto-Immunes MNT: Mycobactéries Non Tuberculeuses MSMD: Mendelian Susceptibility to Mycobacterial Disease NADPH: Nicotinamide Adénine Dinucléotide Phosphate NEMO: Nuclear factor-kappa B Essential Modulator NK/NKT: Natural Killer/ Natural Killer T NOC-2: NO C2 domain PBMC: Peripheral Blood Mononuclear Cells PBS: Phosphate-Buffered Saline PHA: Phytohémagglutinine PRR: Pattern Recognition Receptor ROS: Reactive Oxygen Species RPMI: Roswell Park Memorial Institute STAT: Signal Transducers and Activators of Transcription SOCS-1: Suppressor Of Cytokine Signaling 1 SVF : Sérum de Veau Foetal Tb 7.7: Tuberculosis 7.7 TGF: Transforming Growth Factor TLR: Toll-Like Receptor TNF: Tumor Necrosis Factor VIH : Virus de l'Immunodéficience Humaine VZV : Varicella Zoster Virus